Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine (Q28280887)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine	scientific article

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

Stephanie J Schrag

1

object named as

Stephanie J Schrag

0 references

author name string

Jennifer R Verani

2

0 references

language of work or name

0 references

publication date

28 August 2013

0 references

0 references

31 Suppl 4

0 references

D20-6

0 references

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Antibiotic resistance patterns in invasive group B streptococcal isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Evaluation of Universal Antenatal Screening for Group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Antibiotic use in pregnancy and drug-resistant infant sepsis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Clinical sepsis in neonates and young infants, United States, 1988-2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

The infectious origins of stillbirth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Recurrence of group B streptococci colonization in subsequent pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

What is the best way to use conjugate vaccines?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

First molecular characterization of group B streptococci with reduced penicillin susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.056

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.11.056

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28280887&oldid=1952716273"